Global barriers to GLP-1 receptor agonist treatment in women: access, safety, and equity. // The Lancet Obstetrics, Gynaecology, & Women’s Health. – URL: https://www.sciencedirect.com/science/article/pii/S3050503826002281?dgcid=rss_sd_all
Global barriers to GLP-1 receptor agonist treatment in women: access, safety, and equity. The Lancet Obstetrics, Gynaecology, & Women’s Health. https://www.sciencedirect.com/science/article/pii/S3050503826002281?dgcid=rss_sd_all
“Global barriers to GLP-1 receptor agonist treatment in women: access, safety, and equity.” The Lancet Obstetrics, Gynaecology, & Women’s Health.
@article{article90966,
title = {Global barriers to GLP-1 receptor agonist treatment in women: access, safety, and equity},
journal = {The Lancet Obstetrics, Gynaecology, \& Women’s Health},
url = {https://www.sciencedirect.com/science/article/pii/S3050503826002281?dgcid=rss_sd_all}
}